SEC Filings

DEFR14A
MEDTRONIC PLC filed this Form DEFR14A on 10/11/2017
Entire Document
 

Quality Committee

Elizabeth Nabel, M.D. (Chair)
Shirley Ann Jackson, Ph.D.
Michael O. Leavitt
James T. Lenehan
Denise O’Leary
Robert C. Pozen
  Number of
meetings during
Fiscal Year 2017
41

 

Responsibilities:

 

  Overseeing assessment and making recommendations to the Board regarding the Company’s overall quality strategies and systems to monitor and control product quality and safety, the Company’s response to quality and quality systems assessments conducted by the Company and external regulators, the Company’s response to material quality issues and field actions, and the Company’s technology and cybersecurity strategies, systems, and controls to ensure reliability and prevent unauthorized access.
     
  Overseeing risk management in the area of human and animal studies, including the periodic review of policies and procedures related to the conduct of such studies
     
  Staying informed of major regulatory changes both domestically and internationally to ensure the Company is poised to meet new standards

 

Technology and Value Creation Committee

Michael O. Leavitt (Chair)
Craig Arnold
Scott C. Donnelly
Shirley Ann Jackson, Ph.D.
James T. Lenehan
Elizabeth Nabel, M.D.
Robert C. Pozen
  Number of
meetings during
Fiscal Year 2017
42

 

Responsibilities:

 

  Overseeing assessment and making recommendations to the Board regarding the Company’s product, service, and technology portfolio and its effect on the Company’s growth and performance, emerging science and technology trends that will affect the Company, the Company’s approach to identifying and developing new markets, and the Company’s intellectual property portfolio
     
  Monitoring the overall direction, effectiveness, and competitiveness of the Company’s research and development programs and pipeline
     
  Evaluating the technological aspects of potential acquisitions as requested by the Board
     
  Reviewing and assessing the Company’s competitive standing from a technological point of view
     
  Providing updates to the Quality Committee, as requested, regarding technological advances in cybersecurity
     
  Evaluating the economic value of new and existing products and services

 

1 Effective July 1, 2017, the Quality and Technology Committee split into two separate committees – the Quality Committee and the Technology and Value Creation Committee. This number represents the number of meetings held by the Quality and Technology Committee in Fiscal Year 2017.
2 Effective July 1, 2017, the Quality and Technology Committee split into two separate committees – the Quality Committee and the Technology and Value Creation Committee. This number represents the number of meetings held by the Quality and Technology Committee in Fiscal Year 2017.

 

 MEDTRONIC PLC   2017 Proxy Statement   25

 
X